Finally, further analysis is needed of both BCAR1 and SRCIN1 gene status and regulation in specific breast cancer subtypes, in order to address their real contribution to the biological heterogeneity of human tumors in terms of patient stratification. This evidence concerns the gene BCAR1 and breast cancer.